A Prospective,Multicentral,Open-label,Randomized,Controlled,Phase III Clinical Trial to Compare Chemotherapy With Capecitabine and Oxaliplatin for 4 Months to 6 Months After D2 Gastrectomy for Gastric Cancer Staged II or III.
Phase of Trial: Phase III
Latest Information Update: 22 Jan 2018
At a glance
- Drugs Capecitabine (Primary) ; Oxaliplatin (Primary)
- Indications Adenocarcinoma; Gastric cancer
- Focus Therapeutic Use
- 22 Jan 2018 New trial record